Age, years (mean, SD) |
54.7 (18.6) |
55.7 (22.3) |
54.9 (23.2) |
0.903 |
Female (n, %) |
364 (54.2%) |
51 (52.6%) |
357 (54.8%) |
0.907 |
Non-White (n, %) |
115 (17.1%) |
16 (16.5%) |
130 (20.0%) |
0.360 |
Inpatient at baseline (n, %) |
555 (82.6%) |
72 (74.2%) |
400 (61.4%) |
<0.001 |
Nursing home (n, %) |
7 (1.0%) |
7 (7.2%) |
78 (12.0%) |
<0.001 |
Charlson Deyo Score (mean, SD) |
1.37 (1.60) |
1.32 (1.49) |
1.28 (1.53) |
0.581 |
Antibiotics during past 2 weeks (n, %) |
425 (62.2%) |
54 (54.5%) |
359 (50.6%) |
<0.001 |
Proton pump inhibitors during past 2 weeks (n, %) |
323 (47.3%) |
47 (47.5%) |
228 (32.1%) |
<0.001 |
H2 receptor antagonists during past 2 weeks (n, %) |
132 (19.3%) |
19 (19.2%) |
115 (16.2%) |
0.292 |
Number admissions during previous 28 days: |
|
|
|
|
0 |
577 (85.9%) |
80 (82.5%) |
552 (84.8%) |
|
1 |
86 (12.8%) |
14 (14.4%) |
91 (14.0%) |
|
2+ |
9 (1.3%) |
3 (3.1%) |
8 (1.2%) |
0.614 |
Number nights in hospital during previous 180 days (mean, SD) |
12.6 (16.2) |
13.6 (17.9) |
10.6 (16.7) |
0.042 |
Number prior positive C. difficile tests: |
|
|
|
|
0 |
636 (94.6%) |
80 (82.5%) |
531 (81.6%) |
|
1 |
29 (4.3%) |
13 (13.4%) |
97 (14.9%) |
|
2+ |
7 (1.0%) |
4 (4.1%) |
23 (3.5%) |
<0.001 |